Idorsia Ltd
Develops and commercializes small-molecule medicines for CNS, cardiovascular, and immune disorders.
IDIA | SW
Overview
Corporate Details
- ISIN(s):
- CH0363463438 (+2 more)
- LEI:
- 506700XOVZUB107S5720
- Country:
- Switzerland
- Address:
- Hegenheimermattweg 91, 4123 Allschwil
- Website:
- https://www.idorsia.com/index
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Idorsia Ltd is a biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule medicines. The company focuses on addressing unmet medical needs through a diversified and balanced clinical development pipeline. Its portfolio targets multiple therapeutic areas, including central nervous system (CNS), cardiovascular, and immunological disorders, as well as orphan diseases. Idorsia aims to translate scientific innovation into new treatment options and provides robust scientific information and resources to healthcare professionals and patients through a dedicated portal.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Idorsia Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Idorsia Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Idorsia Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-05-11 | N/A | Non-Executive member | Buy | None | 98,179.90 CHF |
| 2022-05-10 | N/A | Non-Executive member | Buy | None | 109,660.30 CHF |
Peer Companies
